CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST), where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Lab Expectations listing page

Read More →

Hallmarks of Cancer: Genome Instability and Mutation

Genetic alterations are a fundamental characteristic of cancer. When DNA mutations and chromosomal r...
Susan Keezer, PhD Aug 20, 2025

Hallmarks of Cancer: Avoiding Immune Destruction

This blog explores the mechanisms, pathways, and proteins involved in one of the Hallmarks of Cancer...
Emily Alonzo, PhD Aug 13, 2025

CST's Sustainable Supply Chain: Ambient Shipping & Antibody Stability

Did you know that around 60% of CST® antibodies are shipped at room temperature, eliminating the nee...
Alexandra Foley Aug 6, 2025

Three Reasons Flow Cytometry Controls Give You CAR Confidence

Chimeric Antigen Receptor (CAR) cell therapies continue to advance, but the high cost and lengthy ti...
Andrea Tu, PhD Jul 23, 2025

Automating PTM Profiling for Mass Spec: Scalable Proteomics Workflows Using PTMScan® Reagents

Studying post-translational modifications (PTMs) is critical for advancing our understanding of cell...
Barry Zee Jul 16, 2025

Mechanisms of Cell Death: Ferroptosis

What is ferroptosis? Ferroptosis is an iron-dependent form of programmed cell death with distinct mo...
Gary Kasof, PhD Jul 9, 2025

Top 10 Biomarkers Powering Parkinson’s Disease Research

Parkinson’s disease (PD) is a relentless, progressive neurodegenerative disease characterized by the...
Richard Cho, PhD Jun 25, 2025

Mechanisms of Cell Death: Apoptosis

What is apoptosis? Apoptosis is a form of programmed cell death (PCD) characterized by cell shrinkag...
Gary Kasof, PhD Jun 18, 2025

Mapping RNA-Protein Interactions with RBP-eCLIP: Powering Discovery in RNA Biology

Guest author Dr Vince Harjono is an Application Scientist Manager at Eclipsebio. CST and Eclipsebio ...

Key Epithelial-Mesenchymal Transition (EMT) Markers in Cancer

EMT, or epithelial-mesenchymal transition, is a biological process in which epithelial cells gain th...
Susan Keezer, PhD Jun 4, 2025

Targeting the Tumor Microenvironment: Key Markers of the Extracellular Matrix (ECM)

In recent years, cancer researchers have started paying closer attention to the extracellular matrix...
Susan Keezer, PhD May 28, 2025

Immunology: What are myeloid cells and how are they identified?

During hematopoiesis, myeloid cells develop from a common myeloid progenitor (CMP) found in the bone...
Rob MacDonald, PhD May 22, 2025

Immunology: What are lymphoid cells and how are they identified?

In humans, hematopoietic stem cells (HSCs) continuously replenish all types of blood cells via a ser...
Amrik Singh, PhD May 21, 2025

Antibody Toolbox: Neurodegenerative Disease Biomarker Research with Biofluid Samples

Neurodegenerative disease research is in serious need of reliable biomarkers—whether to develop meth...
Supriya Singh, PhD May 14, 2025

Setting the Standard: CST's Commitment to Antibody Validation Through YCharOS

Within the complex landscape of biomedical research, antibodies stand as critical tools for scientif...

Do mRNA and protein levels correlate? Not necessarily.

To what extent does mRNA dictate cellular protein levels? It depends. For decades, scientists have u...
Tyler Levy Apr 23, 2025

      Categories

      25-JRY-19751_TrialSize_Blog Listing Ad

      CST Newsletter

      Popular Posts

      Recent Posts
      blog-footer-landscape-blue-gradient

      About Us

       

      Help & Support

      Resources

      Legal

      For Research Use Only. Not for Use in Diagnostic Procedures.
      © 2025 Cell Signaling Technology, Inc. All Rights Reserved.